Genomic characterization of Bordetella pertussis in South Africa, 2015–2019
F Moosa, M du Plessis, MR Weigand… - Microbial …, 2023 - microbiologyresearch.org
Pertussis remains a public health concern in South Africa, with an increase in reported
cases and outbreaks in recent years. Whole genome sequencing was performed on 32 …
cases and outbreaks in recent years. Whole genome sequencing was performed on 32 …
[HTML][HTML] 全球百日咳防控面临的挑战
张梦， 吴丹， 李艺星， 郑徽， 尹遵栋， 梁晓峰 - 中华流行病学杂志, 2023 - html.rhhz.net
百日咳是由百日咳鲍特菌引起的急性高传染性呼吸道疾病, 是全球婴幼儿疾病和死亡的重要原因
之一. 自1974 年全球逐步将百日咳疫苗纳入扩大免疫规划并维持着较高的疫苗覆盖率. 近年来 …
之一. 自1974 年全球逐步将百日咳疫苗纳入扩大免疫规划并维持着较高的疫苗覆盖率. 近年来 …
[HTML][HTML] Whole-genome comparison of two same-genotype macrolide-resistant Bordetella pertussis isolates collected in Japan
K Koide, Y Uchitani, T Yamaguchi, N Otsuka, M Goto… - Plos one, 2024 - journals.plos.org
The emergence of macrolide-resistant Bordetella pertussis (MRBP) is a significant problem
because it reduces treatment options for pertussis and exacerbates the severity and spread …
because it reduces treatment options for pertussis and exacerbates the severity and spread …
[HTML][HTML] Impact de la vaccination sur l'évolution de Bordetella pertussis
F Lecorvaisier - médecine/sciences, 2024 - medecinesciences.org
Les vaccins contre la coqueluche sont commercialisés et utilisés dans la plupart des pays
du monde depuis déjà plusieurs décennies. L'histoire des vaccins anticoquelucheux est …
du monde depuis déjà plusieurs décennies. L'histoire des vaccins anticoquelucheux est …